Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene

Julia Felden, Britta Baumann, Manir Ali, Isabelle Audo, Carmen Ayuso, Beatrice Bocquet, Ingele Casteels, Blanca Garcia-Sandoval, Samuel G Jacobson, Bernhard Jurklies, Ulrich Kellner, Line Kessel, Birgit Lorenz, Martin McKibbin, Isabelle Meunier, Thomy de Ravel, Thomas Rosenberg, Klaus Rüther, Maria Vadala, Bernd WissingerKatarina Stingl, Susanne Kohl

23 Citationer (Scopus)

Abstract

Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low-visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α-subunit of the G-protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially disease-causing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2-ACHM, we also present detailed clinical data of these patients.

OriginalsprogEngelsk
TidsskriftHuman Mutation
Vol/bind40
Udgave nummer8
Sider (fra-til)1145-1155
Antal sider11
ISSN1059-7794
DOI
StatusUdgivet - aug. 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene'. Sammen danner de et unikt fingeraftryk.

Citationsformater